Published in Prostaglandins Leukot Essent Fatty Acids on September 01, 1993
Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes. Br J Pharmacol (1995) 0.80
Deficient nitric oxide responsible for reduced nerve blood flow in diabetic rats: effects of L-NAME, L-arginine, sodium nitroprusside and evening primrose oil. Br J Pharmacol (1996) 0.77
Vasoreactivity to prostaglandins of rat peripheral nerve. J Physiol (1995) 0.75
Does rectal gonorrhoea reflect unsafe sex? Lancet (1991) 3.99
The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med (2002) 3.22
Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet (1999) 2.37
A flow-sensitive apparatus for studying the responses of the constrictor muscles of perfused tubular organs [proceedings]. J Physiol (1978) 2.14
Preventing the spread of HIV infection. BMJ (1991) 1.88
A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J (2001) 1.59
Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci (1994) 1.50
Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia (1993) 1.44
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. Int J STD AIDS (1996) 1.38
Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care (1998) 1.37
The involvement of noradrenergic nerves in the cardiovascular reflex responses to lower body negative pressure in the anaesthetised rabbit. Pflugers Arch (1976) 1.29
Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia (1983) 1.21
A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain (1998) 1.20
Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes (1999) 1.16
Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain Res (1993) 1.10
Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Diabetes (1984) 1.03
Further evidence for the involvement of microtubules in the intra-axonal movement of noradrenaline storage granules. J Physiol (1971) 1.03
Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Diabetologia (1983) 1.00
Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci (1995) 0.98
Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia (1990) 0.96
Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia (1994) 0.94
A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia (1999) 0.94
Nerve growth factor modulates the activation status and fast axonal transport of ERK 1/2 in adult nociceptive neurones. Mol Cell Neurosci (2001) 0.93
Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy. Diabetologia (2001) 0.93
An analysis of dynamic forces transmitted through the foot in diabetic neuropathy. Diabetes Care (1998) 0.93
Neutrophil sorbitol production impairs oxidative killing in diabetes. Diabet Med (1987) 0.91
Response and cosmetic outcome of two fractionation regimens for AIDS-related Kaposi's sarcoma. Radiother Oncol (1998) 0.91
Nerve growth factor- and neurotrophin-3-induced changes in nociceptive threshold and the release of substance P from the rat isolated spinal cord. J Neurosci (1997) 0.90
NMDA receptor activation modulates evoked release of substance P from rat spinal cord. Br J Pharmacol (1998) 0.90
Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia (1995) 0.90
Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes. Eur J Pharmacol (1993) 0.89
STI prevention and the male sex industry in London: evaluating a pilot peer education programme. Sex Transm Infect (2000) 0.88
Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord. Eur J Neurosci (1997) 0.88
Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Brain Res Mol Brain Res (1994) 0.88
Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy. Diabetes (1990) 0.88
Neurovascular disease, antioxidants and glycation in diabetes. Diabetes Metab Res Rev (2002) 0.88
Aldose reductase inhibitors and diabetic complications. Pharmacol Ther (1992) 0.88
Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats. J Peripher Nerv Syst (1999) 0.87
Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol. J Neurochem (1984) 0.87
Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia (1998) 0.87
Changes in preprotachykinin mRNA expression and substance P levels in dorsal root ganglia of monoarthritic rats: comparison with changes in synovial substance P levels. Brain Res (1995) 0.87
Independent learning packages (audio tape/pamphlet) for a course in cell excitation: evidence that they can be at least as effective as conventional lectures. Med Educ (1979) 0.87
Two populations or granular vesicles in constricted post-ganglionic sympathetic nerves. J Physiol (1975) 0.87
Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats. J Neurochem (1995) 0.86
Interaction between fluconazole and rifampicin. BMJ (1990) 0.85
Proceedings: The noradrenaline concentration and the cholinesterase activity of the separated longitudinal and circular layers of muscle of the guinea-pig vas deferens. Br J Pharmacol (1974) 0.85
Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats. Diabetes (1986) 0.85
Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor. Diabetes (1985) 0.85
Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3. Brain (2003) 0.85
Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor. J Neurol Sci (1989) 0.85
Neurotrophic factors in peripheral neuropathies: pharmacological strategies. Prog Neurobiol (1996) 0.85
Expression of axotomy-inducible and apoptosis-related genes in sensory nerves of rats with experimental diabetes. Brain Res Mol Brain Res (2004) 0.84
Axonal transport of activating transcription factor-2 is modulated by nerve growth factor in nociceptive neurons. J Neurosci (1999) 0.84
Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'. Diabetologia (1987) 0.84
Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition. Diabetologia (1988) 0.84
Ganglioside treatment of streptozotocin-diabetic rats prevents defective axonal transport of 6-phosphofructokinase activity. J Neurochem (1988) 0.83
Insulin partially reverses deficits in peripheral nerve blood flow and conduction in experimental diabetes. J Neurol Sci (1996) 0.83
Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition. J Auton Nerv Syst (1996) 0.83
Autonomic neuropathy in the alloxan-diabetic rat. J Auton Pharmacol (1983) 0.83
An analysis of the response of the perfused vas deferens of the rat to field stimulation [proceedings]. Br J Pharmacol (1978) 0.83
The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin-diabetic rats. Br J Pharmacol (1992) 0.82
Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoceptor agonists. Brain Res Mol Brain Res (2000) 0.82
Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats. Diabetologia (1991) 0.82
alpha-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci Lett (1997) 0.82
Management of mycoses associated with HIV disease. Int J STD AIDS (1996) 0.82
Targeted delivery of nerve growth factor via fibronectin conduits assists nerve regeneration in control and diabetic rats. Eur J Neurosci (1995) 0.82
Reduced levels of mRNA encoding endoskeletal and growth-associated proteins in sensory ganglia in experimental diabetes. Diabetes (1995) 0.82
Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neurosci Lett (1982) 0.82
Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TrkA content of prevertebral and paravertebral rat sympathetic ganglia. Brain Res (2000) 0.82
Does neuropathy develop in animal models? Clin Neurosci (1997) 0.82
Diabetes and axotomy-induced deficits in retrograde axonal transport of nerve growth factor correlate with decreased levels of p75LNTR protein in lumbar dorsal root ganglia. Brain Res Mol Brain Res (1997) 0.81
Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor. Br J Pharmacol (1998) 0.81
Effect of nerve growth factor treatment on p75NTR gene expression in lumbar dorsal root ganglia of streptozocin-induced diabetic rats. Diabetes (1998) 0.81
Axonal transport of substance P-like immunoreactivity in ganglioside-treated diabetic rats. J Neurol Sci (1990) 0.81
Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes. Exp Neurol (1985) 0.81
A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy. Diabetologia (1998) 0.81
Elevated expression of neurotrophin-3 mRNA in sensory nerve of streptozotocin-diabetic rats. Neurosci Lett (1999) 0.81
Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'. Brain Res (1987) 0.81
Alternative splicing of the neurotrophin-3 gene gives rise to different transcripts in a number of human and rat tissues. J Neurochem (2000) 0.81
Impaired nerve regeneration in streptozotocin-diabetic rats is improved by treatment with gangliosides. Exp Neurol (1990) 0.80
Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes. Br J Pharmacol (1995) 0.80
The p75 neurotrophin receptor appears in plasma in diabetic rats-characterisation of a potential early test for neuropathy. Diabetologia (2004) 0.80
Increased nerve growth factor mRNA in lateral calf skin biopsies from diabetic patients. Diabet Med (1999) 0.80
The regeneration of peripheral noradrenergic nerves after chemical sympathectomy in diabetic rats: effects of nerve growth factor. Exp Neurol (1999) 0.80
Defects of axonal transport in diabetes mellitus--a possible contribution to the aetiology of diabetic neuropathy. J Auton Pharmacol (1984) 0.80
Reduced sciatic nerve substance P and calcitonin gene-related peptide in rats with short-term diabetes or central hypoxaemia co-exist with normal messenger RNA levels in the lumbar dorsal root ganglia. Neuroscience (1994) 0.79
Effect of sciatic nerve crush on local and target tissue production of neurotrophin-3 transcripts in rats. Neurosci Lett (1998) 0.79
Axonal transport of cholinergic transmitter enzymes in vagus and sciatic nerves of rats with acute experimental diabetes mellitus; correlation with motor nerve conduction velocity and effects of insulin. Neuroscience (1983) 0.79
The effect of tetrabenazine on the accumulation of noradrenaline in constricted postganglionic sympathetic nerves in vitro. Cell Tissue Res (1975) 0.79
Altered expression of iron transport proteins in streptozotocin-induced diabetic rat kidney. Biochim Biophys Acta (2005) 0.79
Axonal transport of noradrenaline, protein and glycoprotein in cat hypogastric nerves in vitro under conditions of high extracellular glucose. Diabetologia (1983) 0.79
Effect of capsaicin on substance P and nerve growth factor in adjuvant arthritic rats. Neurosci Lett (1997) 0.79
An ultrastructural examination of the action of vinblastine on microtubules, neurofilaments and muscle filaments in vitro. Cell Tissue Res (1976) 0.79
Prevention of defects of axonal transport in experimental diabetes by aldose reductase inhibitors. Drugs (1986) 0.78
Brain-derived neurotrophic factor mRNA levels are up-regulated in hindlimb skeletal muscle of diabetic rats: effect of denervation. Exp Neurol (1996) 0.78
Regenerating sensory neurones of diabetic rats express reduced levels of mRNA for GAP-43, gamma-preprotachykinin and the nerve growth factor receptors, trkA and p75NGFR. Brain Res Mol Brain Res (1996) 0.78
Acidic fibroblast growth factor enhances neurite outgrowth and stimulates expression of GAP-43 and T alpha 1 alpha-tubulin in cultured neurones from adult rat dorsal root ganglia. Neurosci Lett (1996) 0.78